MetaVia Inc. — Director's Dealing 2016

Aug 5, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2016-08-04

Reporting Person: Reno Seth (Chief Commercial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$2.121	2025-08-16	Common Stock (51299)		Direct

Footnotes

F1: The options were granted on August 17, 2015, and began vesting on August 17, 2015, with 10,000 options vesting immediately, and the remaining options vesting in 36 equal monthly increments on the last day of each month.